Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8557
Peer-review started: May 25, 2021
First decision: June 15, 2021
Revised: June 23, 2021
Accepted: August 9, 2021
Article in press: August 9, 2021
Published online: October 6, 2021
Processing time: 126 Days and 5.2 Hours
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, and patients with DLBCL typically present rapidly growing masses. Lymphoma involving muscle is rare and accounts for only 5%; furthermore, multiple muscles and soft tissue involvement of DLBCL is unusual. Due to unusual clinical manifestation, accurate diagnosis could be delayed.
A 61-year-old man complained of swelling, pain and erythematous changes in the lower abdomen. Initially, soft tissue infection was suspected, however, skin lesion did not respond to antibiotics. 18Fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography-computed tomography demonstrated FDG uptake not only in the skin and subcutaneous tissue of the abdomen but also in the abdominal wall muscles, peritoneum, perineum, penis and testis. DLBCL was confirmed by biopsy of the abdominal wall muscle and subcutaneous tissue. After intensive treatment including chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone, central nervous system prophylaxis (intrathecal injection of methotrexate, cytarabine and hydrocortisone) and orchiectomy, he underwent peripheral blood stem cell mobilization for an autologous hematopoietic stem cell transplantation. Despite intensive treatment, the disease progressed rapidly and the patient showed poor outcome (overall survival, 9 mo; disease free survival, 3 mo).
The first clinical manifestation of soft tissue DLBCL involving multiple muscles was similar to the infection of the soft tissue.
Core tip: The majority of diffuse large B-cell lymphomas (DLBCLs) initially present in lymph nodes as rapidly growing masses. Herein, we report an unusual case of DLBCL involving multiple muscles and soft tissue and appearing as soft tissue inflammation. Soft tissue biopsy was performed because there was no response to antibiotics, and DLBCL was confirmed. Despite aggressive chemotherapy and central nervous system (CNS) prophylaxis, the disease recurred with CNS invasion and progressed rapidly. This case highlights that skin invasions of aggressive lymphoma should be considered if there is a soft tissue infection that is unresponsive to antibiotics or progresses rapidly.